| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 16746 |
| 1 | PIOGLITAZONE | 8740 |
| 2 | RANITIDINE HYDROCHLORIDE | 5173 |
| 3 | METFORMIN | 2118 |
| 4 | METFORMIN ER 500 MG | 2015 |
| 5 | METFORMIN ER 750 MG | 2015 |
| 6 | GLIPIZIDE | 794 |
| 7 | INSULIN GLARGINE | 745 |
| 8 | SITAGLIPTIN | 732 |
| 9 | ASPIRIN | 456 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 299 | 0.2358 |
| 1 | PIOGLITAZONE | 8740 | 0.2023 |
| 2 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 7 | 0.1591 |
| 3 | AVANAFIL | 10 | 0.1429 |
| 4 | RANITIDINE HYDROCHLORIDE | 5173 | 0.0955 |
| 5 | PIOGLITAZONE AND GLIMEPIRIDE | 8 | 0.0860 |
| 6 | RANITIDINE | 16746 | 0.0846 |
| 7 | ALITRETINOIN | 4 | 0.0336 |
| 8 | VALRUBICIN | 3 | 0.0169 |
| 9 | USTEKINUMAB-TTWE | 3 | 0.0157 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 1028 |
| 1 | Sulfonylurea [EPC] | 929 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 727 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 707 |
| 4 | Corticosteroid [EPC] | 633 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 465 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 434 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 367 |
| 8 | GLP-1 Receptor Agonist [EPC] | 347 |
| 9 | Proton Pump Inhibitor [EPC] | 339 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 25 | 0.0140 |
| 1 | Sulfonylurea [EPC] | 929 | 0.0075 |
| 2 | Interleukin-17 Receptor A Antagonist [EPC] | 11 | 0.0053 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 17 | 0.0035 |
| 4 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 5 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 154 | 0.0027 |
| 7 | Insulin Analog [EPC] | 1028 | 0.0023 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 5 | 0.0022 |
| 9 | Anthracycline Topoisomerase Inhibitor [EPC] | 5 | 0.0021 |